These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 31312118)

  • 1. Propagation of Tau via Extracellular Vesicles.
    Pérez M; Avila J; Hernández F
    Front Neurosci; 2019; 13():698. PubMed ID: 31312118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The release and trans-synaptic transmission of Tau via exosomes.
    Wang Y; Balaji V; Kaniyappan S; Krüger L; Irsen S; Tepper K; Chandupatla R; Maetzler W; Schneider A; Mandelkow E; Mandelkow EM
    Mol Neurodegener; 2017 Jan; 12(1):5. PubMed ID: 28086931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.
    Reilly P; Winston CN; Baron KR; Trejo M; Rockenstein EM; Akers JC; Kfoury N; Diamond M; Masliah E; Rissman RA; Yuan SH
    Neurobiol Dis; 2017 Oct; 106():222-234. PubMed ID: 28610892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain.
    DeVos SL; Corjuc BT; Oakley DH; Nobuhara CK; Bannon RN; Chase A; Commins C; Gonzalez JA; Dooley PM; Frosch MP; Hyman BT
    Front Neurosci; 2018; 12():267. PubMed ID: 29740275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer's Disease.
    Zhao Y; Liu B; Wang J; Xu L; Yu S; Fu J; Yan X; Su J
    Biomedicines; 2022 Jul; 10(8):. PubMed ID: 35892700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimalistic in vitro systems for investigating tau pathology.
    Hallinan GI; Pitera AP; Patel P; West J; Deinhardt K
    J Neurosci Methods; 2019 May; 319():69-76. PubMed ID: 30278185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of extracellular vesicles in neurodegenerative diseases.
    Quek C; Hill AF
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1178-1186. PubMed ID: 27659705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spreading of tau pathology in Alzheimer's disease by cell-to-cell transmission.
    Mohamed NV; Herrou T; Plouffe V; Piperno N; Leclerc N
    Eur J Neurosci; 2013 Jun; 37(12):1939-48. PubMed ID: 23773063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of secretion and spreading of pathological tau protein.
    Brunello CA; Merezhko M; Uronen RL; Huttunen HJ
    Cell Mol Life Sci; 2020 May; 77(9):1721-1744. PubMed ID: 31667556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia-derived extracellular vesicles in Alzheimer's Disease: A double-edged sword.
    Trotta T; Panaro MA; Cianciulli A; Mori G; Di Benedetto A; Porro C
    Biochem Pharmacol; 2018 Feb; 148():184-192. PubMed ID: 29305855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Serum Exosomes from a Transgenic Mouse Model of Alzheimer's Disease.
    Rosas-Hernandez H; Cuevas E; Raymick JB; Robinson BL; Ali SF; Hanig J; Sarkar S
    Curr Alzheimer Res; 2019; 16(5):388-395. PubMed ID: 30907317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation and Transmission of Tau by Autophagic-Endolysosomal Networks and Potential Therapeutic Targets for Tauopathy.
    Jiang S; Bhaskar K
    Front Mol Neurosci; 2020; 13():586731. PubMed ID: 33177989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological Changes of Tau Related to Alzheimer's Disease.
    Chu D; Liu F
    ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease.
    Wu XL; Piña-Crespo J; Zhang YW; Chen XC; Xu HX
    Chin Med J (Engl); 2017 Dec; 130(24):2978-2990. PubMed ID: 29237931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice.
    Baker S; Polanco JC; Götz J
    J Alzheimers Dis; 2016 Oct; 54(3):1207-1217. PubMed ID: 27567840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles as an emerging tool for the early detection of Alzheimer's disease.
    Li TR; Wang XN; Sheng C; Li YX; Li FZ; Sun Y; Han Y
    Mech Ageing Dev; 2019 Dec; 184():111175. PubMed ID: 31678325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of extracellular Tau in the spreading of neurofibrillary pathology.
    Medina M; Avila J
    Front Cell Neurosci; 2014; 8():113. PubMed ID: 24795568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.